484
Participants
Start Date
December 28, 2023
Primary Completion Date
February 3, 2026
Study Completion Date
February 3, 2028
FARAPULSE™ Pulsed Field Ablation (PFA) System
Subjects will undergo a pulsed field ablation procedure using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the isolation of pulmonary veins and posterior wall.
Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Anti-Arrhythmic Drugs (AADs) including, Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone will be prescribed and monitored in accordance with local clinical practice and already established guideline-directed therapy for patients with persistent atrial fibrillation (AF).
Taipei Veterans General Hospital-Hospital, Taipei
Monash Medical Centre, Clayton
The Prince Charles Hospital, Chermside
Royal Adelaide Hospital-Hospital, Adelaide
Medizinische Univ.-Kliniken Graz-Hospital, Graz
Weill Cornell Medical University, New York
Good Samaritan - Suffern, Suffern
Northwell Health, Bay Shore
Kaleida Health, Buffalo
York Hospital, York
Centro Cardiologico Monzino, Milan
Johns Hopkins Hospital, Baltimore
Chippenham & Johnston-Willis Hospital (CJW), Richmond
Wake Forest University School of Medicine, Winston-Salem
Emory University Hospital, Atlanta
Memorial Health University Medical Center, Savannah
Tallahassee Memorial Hospital, Tallahassee
HCA Florida Mercy Hospital, Miami
St. Joseph's Hospital, Tampa
Sarasota Memorial Hospital, Sarasota
Vanderbilt University Medical Center, Nashville
CHU Grenoble - Hopital Michallon, Grenoble
Baptist Health Lexington, Lexington
OhioHealth Research and Innovation Institute - Riverside Methodist Hospital, Columbus
Cleveland Clinic, Cleveland
Bethesda North Hospital, Cincinnati
Community Heart and Vascular Hospital, Indianapolis
Maria Cecilia Hospital SPA, Cotignola
University of Michigan Hospitals, Ann Arbor
Corewell Health, Grand Rapids
Mercy Hospital Medical Center-Hospital, West Des Moines
University of Iowa Hospitals and Clinics, West Burlington
Aurora St. Luke's Medical Center, Milwaukee
Mayo Clinic Foundation-Hospital, Rochester
AOU delle Marche - PO GM Lancisi, Ancona
Cardioangiologisches Centrum Bethanien, Frankfurt
St. John's Hospital, Springfield
Arrhythmia Research Group, Jonesboro
Oklahoma Heart Institute, Tulsa
Christus Trinity Mother Frances Health System, Tyler
Staedtisches Klinikum Karlsruhe, Karlsruhe
Orion Medical, Houston
Texas Cardiac Arrhythmia Research, Austin
Intermountain Medical Center, Murray
Banner University Medical Center Phoenix, Phoenix
Phoenix Cardiovascular Research Group, Phoenix
Scripps Memorial Hosptial, La Jolla
Cardiology Associates Medical Group, Inc, Ventura
National Heart Centre Singapore, Singapore
Queen Mary Hospital, Hong Kong
Prince of Wales Hospital, Shatin
University of Alabama at Birmingham, Birmingham
Stanford University Medical Center, Palo Alto
Brigham and Women's Hospital, Boston
Southcoast Physicians Group, Fall River
Catholic Medical Center, Manchester
Valley Hospital, Paramus
University of Texas Medical Branch, Galveston
St. Jan, Bruges
Hamilton General Hospital, Hamilton
Institut universitaire de Cardiologie et de Pneumologie de Quebec, Québec
Klinicki Bolnicki Centar Split, Split
Fondazione PTV - Policlinico Tor Vergata, Roma
Hospital Universitario La Fe, Valencia
Lead Sponsor
Boston Scientific Corporation
INDUSTRY